Fetal mouse liver and normal human bone marrow cell cultures were used for studies on the inhibition of erythroid colony formation (CFU-E) by sera from anemic patients with end-stage renal failure and the polyamine spermine. Sera from each of eight predialysis uremic anemic patients with end-stage renal failure produced a significant (P < 0.001) inhibition of erythroid colony formation in the fetal mouse liver cell cultures when compared to sera from normal human volunteers. In vivo or in vitro dialysis of the uremic sera with a 3,500-dalton exclusion limit membrane removed the inhibitor from uremic sera. The uremic serum dialysate provided by the membrane fractionation was significantly inhibitory in the erythroid cell cultures. When this dialysate was applied to gel filtration chromatography (Bio-Gel P-2) the inhibitor was found to be in the same molecular weight range as [14C]spermine. The polyamine spermine produced a dose-related inhibition of erythroid colony formation (CFU-E) in fetal mouse liver and normal human bone marrow cultures. Thus, the following evidence is provided that the in vitro inhibitor of erythropoiesis found in chronic renal failure patients' sera is identical with the polyamine spermine: (a) the inhibitor and radiolabeled spermine appeared in identical Bio-Gel P-2 effluent fractions; (b) when spermine was added to normal human sera at concentrations reported in sera of uremic patients, and studied in both the fetal mouse liver cell culture and normal human bone marrow cultures, a dose-related inhibition of erythroid colony (CFU-E) formation was noted; and (c) the inhibitory effects of crude uremic serum, uremic serum dialysate, and fractions of uremic serum dialysate from a Bio-Gel column, on erythroid colony formation were completely abolished by the addition of a specific rabbit antiserum to spermine.
Heinz W. Radtke, Arvind B. Rege, Max B. Lamarche, Dagmar Bartos, Frantisek Bartos, Robert A. Campbell, James W. Fisher
Year: | 2022 | 2021 | 2020 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2008 | 2006 | 2005 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986 | 1985 | 1984 | 1983 | 1982 | 1981 | 1980 | 1979 | Total |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Citations: | 1 | 1 | 1 | 4 | 1 | 1 | 1 | 2 | 5 | 1 | 3 | 3 | 1 | 2 | 1 | 2 | 3 | 2 | 3 | 3 | 1 | 2 | 1 | 1 | 3 | 2 | 3 | 1 | 3 | 7 | 2 | 7 | 5 | 4 | 6 | 4 | 3 | 1 | 1 | 1 | 99 |
Title and authors | Publication | Year |
---|---|---|
Indoxyl sulfate impairs in vitro erythropoiesis by triggering apoptosis and senescence
Duangchan T, Rattanasompattikul M, Chitchongyingcharoen N, Mas-Oodi S, Promkan M, Rongkiettechakorn N, Korpraphong S, Supokawej A |
Experimental Biology and Medicine | 2022 |
Hematological, immunological, and polyamines alterations in the concomitant occurrence of Fasciola gigantica and hepatic leiomyoma in cattle
S Shahvazi, S Esmaeilzadeh, S Bahrami, H Najafzadeh |
Veterinary Parasitology | 2021 |
Uremic Toxins Affect Erythropoiesis during the Course of Chronic Kidney Disease: A Review
E Hamza, L Metzinger, VM Meuth |
Cells | 2020 |
Physiology and pathophysiology of renal erythropoietin-producing cells
HM Shih, CJ Wu, SL Lin |
Journal of the Formosan Medical Association = Taiwan yi zhi | 2018 |
Biochemical and Clinical Impact of Organic Uremic Retention Solutes: A Comprehensive Update
R Vanholder, A Pletinck, E Schepers, G Glorieux |
Toxins | 2018 |
Generation, clearance, toxicity and monitoring possibilities of unaccounted uremic toxins for improved dialysis prescriptions
JG Atherton, DS Hains, JJ Bissler, BD Pendley, E Lindner |
American journal of physiology. Renal physiology | 2018 |
Anemia in the Young and Old: Diagnosis and Management
RT Means |
2018 | |
Hemodialysis Membranes: For Engineers to Medical Practitioners
S De, A Roy |
2017 | |
Role of anuria in the relationship between indoxyl sulfate and anemia in peritoneal dialysis patients
JY Huang, CW Hsu, CW Yang, CC Hung, WH Huang |
Therapeutics and Clinical Risk Management | 2016 |
Urinary metabolomics and biomarkers of aristolochic acid nephrotoxicity by UPLC-QTOF/HDMS
YY Zhao, DD Tang, H Chen, JR Mao, X Bai, XH Cheng, XY Xiao |
Bioanalysis | 2015 |
Comprehensive Physiology
SN Cheuvront, RW Kenefick |
Comprehensive Physiology | 2014 |
Calcium Sensing Receptor Modulates Extracellular Calcium Entry and Proliferation via TRPC3/6 Channels in Cultured Human Mesangial Cells
K Meng, J Xu, C Zhang, R Zhang, H Yang, C Liao, J Jiao, MP Rastaldi |
PloS one | 2014 |
Nutritional Management of Renal Disease
A Molfino, BR Don, GA Kaysen |
Nutritional Management of Renal Disease | 2013 |
Seldin and Giebisch's The Kidney
CJ Cooper, LD Dworkin, WL Henrich |
Seldin and Giebisch's The Kidney | 2013 |
Cationic uremic toxins affect human renal proximal tubule cell functioning through interaction with the organic cation transporter
CM Schophuizen, MJ Wilmer, J Jansen, L Gustavsson, C Hilgendorf, JG Hoenderop, LP Heuvel, R Masereeuw |
Pflügers Archiv - European Journal of Physiology | 2013 |
Clinical Pharmacokinetics and Pharmacodynamics of Erythropoiesis-Stimulating Agents
S Doshi, W Krzyzanski, S Yue, S Elliott, A Chow, JJ Pérez-Ruixo |
Clinical Pharmacokinetics | 2013 |
Cationic uremic toxins affect human renal proximal tubule cell functioning through interaction with the organic cation transporter
CM Schophuizen, MJ Wilmer, J Jansen, L Gustavsson, C Hilgendorf, JG Hoenderop, LP van den Heuvel, R Masereeuw |
Pflügers Archiv - European Journal of Physiology | 2013 |
Brenner and Rector's The Kidney
C Brugnara, KU Eckardt |
Brenner and Rector's The Kidney | 2012 |
Advances in Clinical Chemistry
M Mahler |
Advances in Clinical Chemistry Volume 54 | 2011 |
Practical Urology: Essential Principles and Practice
CR Chapple, WD Steers |
2011 | |
Anemia of Renal Disease: What it is, what to do and what's new
Chalhoub S, Langston C, Eatroff A |
Journal of Feline Medicine and Surgery | 2011 |
Inhibition of apoptotic signalling in spermine-treated vascular smooth muscle cells by a novel glutathione precursor
I Sinha‑Hikim, R Shen, E Kovacheva, A Crum, ND Vaziri, KC Norris |
Cell Biology International | 2010 |
Landmark advances in the development of erythropoietin
JW Fisher |
Experimental biology and medicine (Maywood, N.J.) | 2010 |
Effects of a novel cystine-based glutathione precursor on oxidative stress in vascular smooth muscle cells
I Sinha-Hikim, R Shen, WN Lee, A Crum, ND Vaziri, KC Norris |
American journal of physiology. Cell physiology | 2010 |
Nocturnal Hemodialysis Improves Erythropoietin Responsiveness and Growth of Hematopoietic Stem Cells
CT Chan, PP Liu, S Arab, N Jamal, HA Messner |
Journal of the American Society of Nephrology : JASN | 2008 |
Polyamines as an Inhibitor on Erythropoiesis of Hemodialysis Patients by In Vitro Bioassay Using the Fetal Mouse Liver Assay
K Yoshida, T Yoneda, S Kimura, K Fujimoto, E Okajima, Y Hirao |
Therapeutic Apheresis and Dialysis | 2006 |
Controversies in renal anemia management
O Ifudu |
Dialysis & Transplantation | 2006 |
Reviews: Uremic Toxins: A New Focus on an Old Subject
A Yavuz, C Tetta, FF Ersoy, V D’intini, R Ratanarat, MD Cal, M Bonello, V Bordoni, G Salvatori, E Andrikos, G Yakupoglu, NW Levin, C Ronco |
Seminars in Dialysis | 2005 |
Low water-soluble uremic toxins
RC Vanholder, G Glorieux, RD Smet, PP de Deyn |
Advances in renal replacement therapy | 2003 |
Erythropoietin: Physiology and Pharmacology Update
JW Fisher |
Experimental biology and medicine (Maywood, N.J.) | 2003 |
Reduced Requirement for Erythropoietin with Quotidian Hemodialysis Therapy
S Klarenbach, AP Heidenheim, R Leitch, RM Lindsay |
ASAIO Journal | 2002 |
Renal Anemia
O Ifudu |
2002 | |
Trends in Anemia Management among US Hemodialysis Patients
JA Coladonato, DL Frankenfield, DN Reddan, PS Klassen, LA Szczech, CA Johnson, WF Owen |
Journal of the American Society of Nephrology : JASN | 2002 |
Role of uremic toxins in exacerbating anemia in renal failure
IC Macdougall |
Kidney International | 2001 |
Adequacy of dialysis reduces the doses of recombinant erythropoietin independently from the use of biocompatible membranes in haemodialysis patients
E Movilli, GC Cancarini, R Zani, C Camerini, M Sandrini, R Maiorca |
Nephrology Dialysis Transplantation | 2001 |
Gene Electrotransfer Results in a High-Level Transduction of Rat Skeletal Muscle and Corrects Anemia of Renal Failure
G Rizzuto, M Cappelletti, C Mennuni, MI Wiznerowicz, A Demartis, D Maione, G Ciliberto, NL Monica, E Fattori |
Human Gene Therapy | 2000 |
Adequacy of dialysis and differences in hematocrit among dialysis facilities
O Ifudu, J Uribarri, I Rajwani, V Vlacich, K Reydel, G Delosreyes, EA Friedman |
American Journal of Kidney Diseases | 2000 |
Anaemia correction—does the mode of dialysis matter?
KU Eckardt |
Nephrology Dialysis Transplantation | 2000 |
The Anemia in Continuous Ambulatory Peritoneal Dialysis Patients Is Related to Kt/V Index
K Opatrny, S Opatrna, F Sefrna, J Wirth |
Artificial Organs | 1999 |
Functional Iron Deficiency and Inadequate Dialysis: Is There a Connection?
O Ifudu |
The International Journal of Artificial Organs | 1999 |
Insulin-Like Growth Factor I Plays a Role in Regulating Erythropoiesis in Patients with End-Stage Renal Disease and Erythrocytosis
LY Shih, JY Huang, CT Lee |
Journal of the American Society of Nephrology : JASN | 1999 |
A QUEST FOR ERYTHROPOIETIN OVER NINE DECADES
JW Fisher |
Annual Review of Pharmacology and Toxicology | 1998 |
Influence of bisphosphonate on the negative erythropoietic effects of uranyl nitrate
MJ Giglio, A Frid, CE Bozzini |
International Journal of Clinical & Laboratory Research | 1997 |
Erythropoietin in the pathogenesis and treatment of the anemia of chronic renal failure
AJ Erslev, A Besarab |
Kidney International | 1997 |
The Intensity of Hemodialysis and the Response to Erythropoietin in Patients with End-Stage Renal Disease
O Ifudu, J Feldman, EA Friedman |
New England Journal of Medicine | 1996 |
l-Carnitine effects on anemia in hemodialyzed patients treated with erythropoietin
WD Labonia |
American Journal of Kidney Diseases | 1995 |
Middle Molecules as Uremic Toxins: Still a Viable Hypothesis?
R Vanholder |
Seminars in Dialysis | 1994 |
Transforming growth factor beta 1 is an inducer of erythroid differentiation
G Krystal, V Lam, W Dragowska, C Takahashi, J Appel, A Gontier, A Jenkins, H Lam, L Quon, P Lansdorp |
Journal of Experimental Medicine | 1994 |
Advances in Pharmacology
B Drenger, Y Ginosar, Y Gozal |
Advances in Pharmacology | 1994 |
Burst‐promoting activity in the serum of patients with chronic renal failure undergoing long‐term hemodialysis
G Randall, J Meyer, C Swanepoel, P Jacobs |
Stem Cells | 1993 |
Epoetin: A Pharmacoeconomic Review of its Use in Chronic Renal Failure and its Effects on Quality of Life
R Whittington, LB Barradell, P Benfield |
PharmacoEconomics | 1993 |
A comparison of the responses to recombinant human erythropoietin in normal and uremic subjects
JW Eschbach, NR Haley, JC Egrie, JW Adamson |
Kidney International | 1992 |
The existence of activin A / erythroid differentiation factor and its inhibitor in human serum: Comparison of normal and chronic renal failure sera
M Shiozaki, R Sakai, M Tabuchi, M Shinohara, M Kosaka, S Saito, Y Eto |
Biochemical and Biophysical Research Communications | 1992 |
Biochemical Pharmacology of Blood and Bloodforming Organs
JW Fisher |
1992 | |
Polyamines in the anemia of end-stage renal disease
D Kushner, B Beckman, L Nguyen, S Chen, CD Santina, F Husserl, J Rice, JW Fisher |
Kidney International | 1991 |
Pharmacokinetics of intravenous recombinant human erythropoietin in patients with chronic renal failure
T Salmonson, BG Danielson, A Grahnén, B Wikström |
Journal of Internal Medicine | 1990 |
Effects of Theophylline on Erythropoietin Production in Normal Subjects and in Patients with Erythrocytosis after Renal Transplantation
GL Bakris, ER Sauter, JL Hussey, JW Fisher, AO Gaber, R Winsett |
New England Journal of Medicine | 1990 |
Growth Factors, Differentiation Factors, and Cytokines
A Habenicht |
1990 | |
The anemia of chronic renal failure: Pathophysiology and the effects of recombinant erythropoietin
JW Eschbach |
Kidney International | 1989 |
Recent Developments in the Anemia of Chronic Renal Failure
A Besarab, JF Girone, A Erslev, J Caro |
Seminars in Dialysis | 1989 |
Prostaglandin-mediated suppression of in vitro growth of erythroid progenitor cells
S Taniguchi, T Shibuya, M Harada, Y Niho |
Kidney International | 1989 |
Hematologic aspects of renal insufficiency
GJ Schiller, SA Berkman |
Blood Reviews | 1989 |
Treatment of fetal bovine serum with activated charcoal enhances spontaneous differentiation of murine erythroleukemia cells
T Murate, T Kaneda |
Leukemia Research | 1989 |
Serum Erythropoietin Levels after Renal Transplantation
CH Sun, H Ward, WL Paul, MA Koyle, N Yanagawa, DB Lee |
New England Journal of Medicine | 1989 |
New Perspectives in Hemodialysis, Peritoneal Dialysis, Arteriovenous Hemofiltration, and Plasmapheresis
WH Hörl, PJ Schollmeyer |
1989 | |
The anemia of end-stage renal disease: Hematopoietic progenitor cell response
GM Segal, JW Eschbach, JC Egrie, T Stueve, JW Adamson |
Kidney International | 1988 |
Recombinant Human Erythropoietin: Implications for Nephrology
JW Eschbach, JW Adamson |
American Journal of Kidney Diseases | 1988 |
Erythropoietin–hematocrit feedback circuit in the anemia of end–stage renal disease
AJ Walle, GY Wong, GK Clemons, JF Garcia, W Niedermayer |
Kidney International | 1987 |
Spermine and spermidine are non-specific inhibitors of in vitro hematopoiesis
GM Segal, T Stueve, JW Adamson |
Kidney International | 1987 |
Correction of the Anemia of End-Stage Renal Disease with Recombinant Human Erythropoietin
JW Eschbach, JC Egrie, MR Downing, JK Browne, JW Adamson |
New England Journal of Medicine | 1987 |
Polycythemia in Chronic Obstructive Pulmonary Disease
B Guidet, G Offenstadt, G Boffa, A Najman, C Baillou, C Hatzfeld, P Amstutz |
Chest | 1987 |
Hematologic Abnormalities in Patients with Renal Diseases
WG Hocking |
Hematology/Oncology Clinics of North America | 1987 |
Uremic Toxins
S Ringoir, R Vanholder, SG Massry |
1987 | |
Chronic Ambulatory Peritoneal Dialysis (CAPD) and Chronic Cycling Peritoneal Dialysis (CCPD) in Children
RN Fine |
1987 | |
Is lower ploidy of megakaryocytes another reason for uremic thrombocytopathy?
M Winkelmann, U Dorr, P Pfitzer, W Schneider |
Klinische Wochenschrift | 1986 |
Hematopoietic inhibitors in chronic renal failure: Lack of in vitro specificity
F Delwiche, GM Segal, JW Eschbach, JW Adamson |
Kidney International | 1986 |
Potential Role of Serum Inhibitors of Erythropoiesis in the Anemia Associated With Infection, Renal Disease and Malignancy in the Dog
DJ Weiss |
Veterinary Clinical Pathology | 1986 |
The anaemia of chronic renal failure: A potentially treatable catabolic phenomenon?
JS Shannon, TR Lappin |
Medical Hypotheses | 1986 |
Toxins and Inhibitors in Chronic Renal Failure
D Powell, J Bergstrom, R Dzurik, P Gulyassy, D Lockwood, L Phillips |
American Journal of Kidney Diseases | 1986 |
Anemia of end-stage renal disease (ESRD)
JW Eschbach, JW Adamson |
Kidney International | 1985 |
Polyamines in clinical disorders
DF Tierney, LJ Marton, AD Hacker, N Lowe |
The Western journal of medicine | 1985 |
Effect of amines on erythropoietin-stimulated heme synthesis in fetal mouse liver cells
JT Dulaney, FE Hatch, J Young |
Life Sciences | 1985 |
Aluminum-Induced Anemia
L Kaiser, KA Schwartz |
American Journal of Kidney Diseases | 1985 |
The anemia of chronic renal failure in sheep. Response to erythropoietin-rich plasma in vivo
JW Eschbach, J Mladenovic, JF Garcia, PW Wahl, JW Adamson |
Journal of Clinical Investigation | 1984 |
Erythropoietin deficiency and inhibition of erythropoiesis in renal insufficiency
RJ McGonigle, JD Wallin, RK Shadduck, JW Fisher |
Kidney International | 1984 |
The anaemia of chronic renal failure in sheep: studies in vitro
J Mladenovic, JW Eschbach, JF Garcia, JW Adamson |
British Journal of Haematology | 1984 |
Hemodialysis and continuous ambulatory peritoneal dialysis effects on erythropoiesis in renal failure
RJ McGonigle, F Husserl, JD Wallin, JW Fisher |
Kidney International | 1984 |
Inhibition of Erythropoiesis in Chronic Renal Failure: The Role of Parathyroid Hormone
JD Lutton, KB Solangi, NG Ibraham, AI Goodman, RD Levere |
American Journal of Kidney Diseases | 1984 |
Therapy of Renal Diseases and Related Disorders
WN Suki, SG Massry |
1984 | |
Deficient feedback regulation of erythropoiesis in kidney transplant patients with polycythemia
F Thevenod, HW Radtke, P Grützmacher, E Vincent, KM Koch, W Schoeppe, W Fassbinder |
Kidney International | 1983 |
Influence of continuous ambulatory peritoneal dialysis on the anemia of endstage renal disease
MB de Paepe, KH Schelstraete, SM Ringoir, NH Lameire |
Kidney International | 1983 |
Determination of polyamines in hydrolysates of uremic plasma by high-performance cation-exchange column chromatography
T Takagi, TG Chung, A Saito |
Journal of Chromatography B: Biomedical Sciences and Applications | 1983 |
Ribonuclease Inhibition of Erythropoiesis in Anemia of Uremia
MH Freedman, EF Saunders, DC Cattran, EZ Rabin |
American Journal of Kidney Diseases | 1983 |
Erythropoietin-independent erythroid colony formation in patients with erythroleukaemia (M6) and related disorders
WF Anderson, B Beckman, G Beltran, JW Fisher, WJ Stuckey |
British Journal of Haematology | 1982 |
Mixed myeloid—lymphoid colonies in a patient with polycythemia vera
B Beckman, WF Anderson, G Beltran, I Chen, JW Fisher |
American Journal of Hematology | 1982 |
Normalization of hematocrit in patients with end-stage renal disease on continuous ambulatory peritoneal dialysis
AR Zappacosta, J Caro, A Erslev |
The American Journal of Medicine | 1982 |
Contemporary Nephrology
S Klahr, SG Massry |
1981 | |
Verhandlungen der Deutschen Gesellschaft für innere Medizin
B Schlegel |
1980 | |
Replacement of Renal Function by Dialysis
W Drukker, FM Parsons, JF Maher |
1979 |